LIFTT guida l’investimento in Evoralis, spin-out di Cambridge, per sviluppare il riciclo enzimatico dei tessuti Your browser does not seem to support iframes. Click here to read this PDF.Your browser does not seem to support iframes. Click here to read this PDF. Created using FlowPaper Flipbook Maker ↗ LIFTT Venture Capital Italia2024-09-17T12:33:37+02:0017 Settembre 2024| Share FacebookXLinkedInWhatsAppEmail